| Annual Financials | 2023 | 2024 | 2025 | TTM |
Revenue  | 16 | 15 | 38 | 0 |
| Expenses | 15 | 10 | 23 | 0 |
| EBITDA | 2 | 6 | 15 | 0 |
| Operating Profit % | 10 % | 37 % | 40 % | 0 % |
| Depreciation | 1 | 1 | 1 | 0 |
| Interest | 1 | 1 | 1 | 0 |
| Profit Before Tax | 1 | 4 | 13 | 0 |
| Tax | 0 | 1 | 3 | 0 |
| Net Profit | 0 | 3 | 10 | 0 |
| EPS in ₹ | 0.36 | 2.72 | 10.67 | 0.00 |
Bio Medica Laboratories
Bio Medica Laboratories
135.50
-2.50
(-1.81%)
Market Cap
170.39 Cr
PE Ratio
-
Volume
15,000.00
Day High - Low
137.15 - 135.50
52W High-Low
142.00 - 101.50
Key Fundamentals
Market Cap
170.39 Cr
EPS
10.67
PE Ratio
-
PB Ratio
-
Book Value
49.24
EBITDA
15.30
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
66.48
Debt to Equity
1.30
Actual
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,868.00 | #1 4,48,195.77 | 38.85 | #1 58,220.10 | 6.38 | #1 11,565 | 25.80 | 64.62 | |
6,747.00 | 1,79,111.65 | 70.14 | 10,560.00 | 8.73 | 2,520 | 13.44 | 57.29 | |
4,514.10 | 1,52,777.66 | 70.56 | 13,886.20 | 20.34 | 2,138 | -26.91 | 52.62 | |
1,433.10 | 1,15,763.05 | 29.61 | 29,044.60 | 2.24 | 3,870 | -55.32 | 60.96 | |
1,112.20 | 1,11,913.34 | 21.30 | 26,719.70 | 13.65 | 5,242 | 7.82 | 59.83 | |
1,301.30 | 1,08,612.10 | 25.92 | 33,593.30 | -0.44 | 3,998 | -86.05 | 53.01 | |
2,357.80 | 1,07,761.65 | #1 19.97 | 27,487.50 | 19.98 | 5,345 | #1 87.72 | 59.95 | |
2,528.60 | 1,04,381.89 | 54.06 | 14,277.60 | 12.03 | 1,750 | 31.75 | 68.38 | |
1,534.20 | 89,106.59 | 24.74 | 33,384.70 | 3.21 | 3,376 | 1.99 | 58.58 | |
1,481.00 | 79,952.76 | 87.15 | 6,867.80 | #1 22.01 | 890 | 21.18 | 67.21 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
150.33 %
Net Income Growth
292.00 %
Cash Flow Change
-326.54 %
ROE
31.38 %
ROCE
82.15 %
EBITDA Margin (Avg.)
7.26 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2023 | 2024 | 2025 |
| Total Assets | 18 | 20 | 39 |
| Fixed Assets | 8 | 9 | 8 |
| Current Assets | 9 | 11 | 31 |
| Capital Work in Progress | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 |
| Other Assets | 9 | 11 | 31 |
| Total Equity & Liabilities | 18 | 20 | 39 |
| Current Liabilities | 10 | 7 | 17 |
| Non Current Liabilities | 5 | 8 | 7 |
| Total Equity | 2 | 5 | 15 |
| Reserve & Surplus | 2 | 5 | 6 |
| Share Capital | 0 | 0 | 9 |
Cash Flow
| Cash Flow | 2023 | 2024 | 2025 |
| Net Cash Flow | -2 | 0 | 0 |
| Investing Activities | -2 | -2 | 0 |
| Operating Activities | 2 | 2 | -4 |
| Financing Activities | -2 | -0 | 3 |
Share Holding
| % Holding | Aug 2025 | May 2026 |
| Promoter | 100.00 % | 67.70 % |
| FIIs | 0.00 % | 0.29 % |
| DIIs | 0.00 % | 2.31 % |
| Government | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 21.38 % |
| Others | 0.00 % | 8.33 % |
| No of Share Holders | 0 | 1,195 |
Technical Indicators
RSI(14)
Neutral 65.09
ATR(14)
Less Volatile 7.24
STOCH(9,6)
Overbought 82.73
STOCH RSI(14)
Oversold 0.00
MACD(12,26)
Bearish 0.00
ADX(14)
Weak Trend 0.00
UO(9)
Bullish 0.00
ROC(12)
Uptrend And Accelerating 18.25
WillR(14)
Overbought -9.88
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
